J Patrick Caulfield

Suggest Changes
Learn More
This study evaluated the potential pharmacokinetic interaction of pamapimod, a p38 mitogen-activated protein kinase inhibitor, and methotrexate (MTX) when administered concomitantly in patients with(More)
  • 1